1-(HETERO)ARYLVINYL-5H-2,3- BENZODIAZEPINDERIVATIVE VERWENDBAR ZUR BEHANDLUNG VON ERKRANKUNGEN DES ZENTRALNERVENSYSTEMS, SOWIE BENZOPYRYLIUM INTERMEDIATE ZU IHRER HERSTELLUNG

1-(HETERO)ARYLVINYL-5H-2,3- BENZODIAZEPINDERIVATIVE VERWENDBAR ZUR BEHANDLUNG VON ERKRANKUNGEN DES ZENTRALNERVENSYSTEMS, SOWIE BENZOPYRYLIUM INTERMEDIATE ZU IHRER HERSTELLUNG

2,3-benzodiazepine derivatives of general formulawhereinA and Btogether form a group of formula   = C = N - orR1represents phenyl, optionally carrying 2 or 3 hydroxy groups or 1 to 3 substituent(s) selected from the group consisting of halogen, trifluoromethyl, nitro, cyano, amino, C1-3-alkylamino,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: BAJNOGEL, JUDIT, ANDRASI, FERENC, HORVATH, EDIT, SIMIG, GYULA, MATE, GYOERGYNE, GYERTYAN, ISTVAN, BOTKA, PETER, KOEROESI, JENO, REITER, JOZSEF, SALAMON HASKANE, CECILIA, DAROCZI KAZONE, KLARA, GACSALYI, ISTVAN, EGYED, ANDRAS, HAMORI, TAMAS, SZENTKUTI, ESZTER, ZOLYOMI, GABOR, BERZSENSYI, PAL, MORAVCSIK, IMRE, BAKONYI, ANNA, BLASKO, GABOR, TIHANYI, KAROLY, BILKEI-GORZO, ANDRAS, VAGO, PAL, HORVATH, KATALIN
Format: Patent
Sprache:ger
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:2,3-benzodiazepine derivatives of general formulawhereinA and Btogether form a group of formula   = C = N - orR1represents phenyl, optionally carrying 2 or 3 hydroxy groups or 1 to 3 substituent(s) selected from the group consisting of halogen, trifluoromethyl, nitro, cyano, amino, C1-3-alkylamino, di-(C1-3 alkyl)-amino, C1-4-alkanoylamino, C1-4-alkyl, C1-4-alkoxy, carboxy, (C1-4-alkoxy)-carbonyl, (C1-4-alkoxy)-carbonyloxy, and methylenedioxy; naphthyl, optionally carrying a substituent selected from the group consisting of hydroxy, C1-4-alkoxy and C1-4-alkanoyloxy; furyl, thienyl or indolyl;R2stands for hydrogen or C1-4-alkyl;R3 and R4represent C1-4-alkoxy attached to positions 7 and 8 of the benzodiazepine ringorR3 and R4together form a 7,8- or 8,9-methylenedioxy group, and their use for preparing medicaments, particularly for the treatment of central nervous system disorders.